Cancer Care Associates - Midtown Tulsa

Tulsa, Oklahoma 74104

0 studies enrolling now · 13 studies all time

What they study most

Cervical Cancer, Endometrial Cancer, Fallopian Tube Cancer, Gestational Trophoblastic Tumor, Neurotoxicity, Ovarian Cancer, Peripheral Neuropathy, Primary Peritoneal Cavity Cancer, Sarcoma, Sexuality and Reproductive Issues, Unspecified Adult Solid Tumor, Protocol Specific

Studies at this site

• Topotecan in Treating Women With Persistent or Recurrent Cervical Cancer — Completed
• Paclitaxel and Carboplatin in Treating Patients With Persistent or Recurrent Stage III or Stage IV Uterine Cancer — Completed
• Topotecan in Treating Patients With Recurrent Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer — Completed
• Cetuximab and Cisplatin in Treating Patients With Advanced, Persistent, or Recurrent Cervical Cancer — Completed
• Pemetrexed Disodium in Treating Patients With Ovarian Epithelial Cancer or Primary Peritoneal Cancer — Completed
• Pemetrexed Disodium in Treating Patients With Persistent or Recurrent Endometrial Cancer — Completed
• Pemetrexed Disodium in Treating Patients With Recurrent Cancer of the Cervix — Completed
• Docetaxel, Gemcitabine, and Filgrastim (G-CSF) or Pegfilgrastim in Treating Patients With Advanced, Persistent, or Recurrent Uterine Leiomyosarcoma — Completed
• Amifostine in Treating Peripheral Neuropathy in Patients Who Have Received Chemotherapy for Cancer — Completed
• EF5 to Detect Tumor Hypoxia in Patients With Stage IIB, Stage IIIB, or Stage IVA Cervical Cancer — Completed
• Vaginal Changes and Sexual Function in Patients With Cervical Cancer — Completed
• Radiation Therapy, Paclitaxel, and Cisplatin in Treating Patients With Cancer of the Cervix — Completed
• Proteomic Profiling in Diagnosing Ovarian Cancer in Patients Who Are Undergoing Surgery for an Abnormal Pelvic Mass — Status unconfirmed